Open AccessIncreased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption of antiretroviral therapy
Author(s) -
Emmanouil Papasavvas,
Livio Azzoni,
Maxwell Pistilli,
Aidan S. Hancock,
Griffin Reynolds,
Cecile Gallo,
Joe Ondercin,
Jay R. Kostman,
Karam Mounzer,
Jane Shull,
Luis J. Montaner
Publication year - 2008
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e328303be2a
Subject(s) - cell adhesion molecule , intercellular adhesion molecule 1 , intercellular adhesion molecule , immunology , von willebrand factor , soluble cell adhesion molecules , cd38 , cell adhesion , medicine , viral load , cd8 , adhesion , chemistry , biology , virus , immune system , microbiology and biotechnology , platelet , stem cell , organic chemistry , cd34
We investigated the effect of short viremic episodes on soluble markers associated with endothelial stress and cardiovascular disease risk in chronically HIV-1-infected patients followed during continuous antiretroviral therapy, antiretroviral therapy interruption and antiretroviral therapy resumption.